PD-L1 expression in various canine malignant cancers.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
PD-L1 expression in various canine malignant cancers.
应用场景：
创建时间：
2016-06-13
相关数据集
Table_5_PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.xls
Treatment-resistant glioma stem cells are thought to propagate and drive growth of malignant gliomas, but their markers and our ability to target them specifically are not well understood. We demonstr
NIAID Data Ecosystem180
Local Immune and Microbiological Responses to Mucosal Administration of a Liposome-TLR Agonist Immunotherapeutic in Dogs. Immune responses to intranasal immunotherapy in dogs
Background: Non-specific immunotherapeutics have been evaluated previously in dogs, primarily for cancer treatment. However, there remains a need for a more broadly targeted, general purpose immunothe
NIAID Data Ecosystem80
Targeting PD-1/PD-L1 in biliary tract cancer: role and available data. Supplementary tables
Supplementary table 1 and 2
Taylor & Francis Group2024-05-16 更新50
table1_Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?.docx
Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
NIAID Data Ecosystem100
Monocyte and neutrophils phagocytic index (% of positive cells) from dogs fed diets with the addition of different yeast cell wall preparations (mean and standard error of the mean).
Monocyte and neutrophils phagocytic index (% of positive cells) from dogs fed diets with the addition of different yeast cell wall preparations (mean and standard error of the mean).
NIAID Data Ecosystem60
